These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 18701471

  • 1. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.
    Levin AM, Machiela MJ, Zuhlke KA, Ray AM, Cooney KA, Douglas JA.
    Cancer Res; 2008 Aug 15; 68(16):6492-5. PubMed ID: 18701471
    [Abstract] [Full Text] [Related]

  • 2. Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population.
    Zhou CH, Wang JY, Cao SY, Shi XH, Zhang YG, Liu M, Wang X, Huang J, Yang YG, Wei D, Yang Z.
    Chin J Cancer; 2011 Oct 15; 30(10):721-30. PubMed ID: 21959049
    [Abstract] [Full Text] [Related]

  • 3. Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.
    Rojas PA, Torres-Estay V, Cerda-Infante J, Montecinos VP, Domínguez J, Arenas J, Godoy AS, San Francisco IF.
    J Cancer Res Clin Oncol; 2014 May 15; 140(5):783-8. PubMed ID: 24627192
    [Abstract] [Full Text] [Related]

  • 4. Pathological outcomes associated with the 17q prostate cancer risk variants.
    Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ.
    J Urol; 2009 Jun 15; 181(6):2502-7. PubMed ID: 19371897
    [Abstract] [Full Text] [Related]

  • 5. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.
    Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA.
    Int J Cancer; 2008 Jun 15; 122(12):2876-9. PubMed ID: 18360876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Common variation in the BRCA1 gene and prostate cancer risk.
    Douglas JA, Levin AM, Zuhlke KA, Ray AM, Johnson GR, Lange EM, Wood DP, Cooney KA.
    Cancer Epidemiol Biomarkers Prev; 2007 Jul 15; 16(7):1510-6. PubMed ID: 17585057
    [Abstract] [Full Text] [Related]

  • 8. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
    Sun J, Zheng SL, Wiklund F, Isaacs SD, Purcell LD, Gao Z, Hsu FC, Kim ST, Liu W, Zhu Y, Stattin P, Adami HO, Wiley KE, Dimitrov L, Sun J, Li T, Turner AR, Adams TS, Adolfsson J, Johansson JE, Lowey J, Trock BJ, Partin AW, Walsh PC, Trent JM, Duggan D, Carpten J, Chang BL, Grönberg H, Isaacs WB, Xu J.
    Nat Genet; 2008 Oct 15; 40(10):1153-5. PubMed ID: 18758462
    [Abstract] [Full Text] [Related]

  • 9. A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
    Liu M, Suzuki M, Arai T, Sawabe M, Enomoto Y, Nishimatsu H, Kume H, Homma Y, Kitamura T.
    Prostate; 2011 Jul 15; 71(10):1023-32. PubMed ID: 21557267
    [Abstract] [Full Text] [Related]

  • 10. 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.
    Chan JY, Li H, Singh O, Mahajan A, Ramasamy S, Subramaniyan K, Kanesvaran R, Sim HG, Chong TW, Teo YY, Chia SE, Tan MH, Chowbay B.
    Urol Oncol; 2013 Nov 15; 31(8):1553-60. PubMed ID: 22561070
    [Abstract] [Full Text] [Related]

  • 11. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
    Loeb S, Helfand BT, Kan D, Isaacs WB, Catalona WJ.
    BJU Int; 2009 Nov 15; 104(9):1200-3. PubMed ID: 19627283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X, Cowper-Sal lari R, Bailey SD, Moore JH, Lupien M.
    Genome Res; 2012 Aug 15; 22(8):1437-46. PubMed ID: 22665440
    [Abstract] [Full Text] [Related]

  • 14. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC, Liu W, Duggan D, Carpten JD, Grönberg H, Xu J, Chang BL, Partin AW, Walsh PC, Isaacs WB, Zheng SL.
    Prostate; 2008 May 15; 68(7):691-7. PubMed ID: 18361410
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.
    Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Dimmer JB, Montie JE, Trent JM, Cooney KA.
    Prostate; 2003 Dec 01; 57(4):326-34. PubMed ID: 14601029
    [Abstract] [Full Text] [Related]

  • 16. Association of six susceptibility Loci with prostate cancer in northern chinese men.
    Zhang YR, Xu Y, Yang K, Liu M, Wei D, Zhang YG, Shi XH, Wang JY, Yang F, Wang X, Liang SY, Zhao CX, Wang F, Chen X, Sun L, Zhu XQ, Zhu L, Yang YG, Tang L, Jiao HY, Huo ZH, Yang Z.
    Asian Pac J Cancer Prev; 2012 Dec 01; 13(12):6273-6. PubMed ID: 23464444
    [Abstract] [Full Text] [Related]

  • 17. Early onset prostate cancer has a significant genetic component.
    Lange EM, Salinas CA, Zuhlke KA, Ray AM, Wang Y, Lu Y, Ho LA, Luo J, Cooney KA.
    Prostate; 2012 Feb 01; 72(2):147-56. PubMed ID: 21538423
    [Abstract] [Full Text] [Related]

  • 18. Racial disparities in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1β gene and prostate cancer: a systematic review and meta-analysis.
    Xiang YZ, Jiang SB, Zhao J, Xiong H, Cui ZL, Li GB, Jin XB.
    Genet Mol Res; 2014 Aug 28; 13(3):6582-92. PubMed ID: 25177939
    [Abstract] [Full Text] [Related]

  • 19. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Grönberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J, International Consortium for Prostate Cancer Genetics.
    Hum Genet; 2012 Jul 28; 131(7):1095-103. PubMed ID: 22198737
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
    Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL.
    Prostate; 2009 Mar 01; 69(4):363-72. PubMed ID: 19058137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.